New hope for cervical cancer? trial tests immune-boosting drugs, but study stopped early
Disease control
Terminated
This study tested two experimental drugs (AGEN2034 alone or with AGEN1884) in 211 women with advanced cervical cancer that came back after standard chemotherapy. The goal was to see if the drugs could shrink tumors. The trial was terminated early, so results are limited. Particip…
Phase: PHASE2 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC